From the data (and previous observations at Penn State), it appears that resistant strains of the pathogen at our research plots limit disease suppression with the DMI fungicides. In previous trials at UConn where resistance was not an issue, good control with the DMI's was achieved. My observations from the past 5 years of data indicate that delaying the onset of dollar spot through early season fungicide applications serves two functions: 1) the delayed onset of disease gives superintendents more time to catch the disease once symptoms do start to appear; and 2) dollar spot suppression later in the season appears to be manageable as the disease doesn't appear to get out of hand during the fall.
Other issues in the region...
Perhaps if the poll had been posted one week later anthracnose may have taken the lead. In last week's posts from the West and South Central, Frank and Megan posted about rising anthracnose samples in their regions. Reports around the Northeast (from Rutgers) indicated that anthracnose activity was picking up as well. A walk through some of our plots at Penn State also indicated that anthracnose was increasing. However, this increase in anthracnose was on the creeping bentgrass. Disease activity on our annual bluegrass trials, however, remain very low. Pythium blight was also ranked as a moderate problem and the disease did make an appearance on some fine leaf fescue plots in the last week or so. At this point in time around the region, you can find just about every typical disease including summer patch, fairy ring, anthracnose, Pythium, brown patch, dollar spot, and others. Everyone SHOULD be able to see the light at the end of the tunnel, however, as core cultivation programs are about to begin and temperatures suitable for turfgrass growth resume in the next few weeks.
2 Responses to “Poll Results: and the winner is...”
This is interesting John! We find that Curalan doesn't work at all in our early-season trials. Funny how these things work.
Good stuff...Curalan has held up consistently in our trials at UConn's research facility, a golf course in Hartford, and now at Penn State's facility. I am not sure of the history of dicarboximide use is at your sites, but your results are definitely something to note in terms of potential regional differences in disease control. Isn't that why we started this blog? Very useful info.
Post a Comment